Robot Immune System

Project Information

RIS

Grant agreement ID: 877268

DOI

10.3030/877268

Project closed

EC signature date 31 July 2019

Start date 1 July 2019

End date 30 November 2019

Funded under

• INDUSTRIAL LEADERSHIP - Innovation In SMEs

Total cost

€ 71 429,00

EU contribution

€ 50 000,00

Coordinated by

ALIAS ROBOTICS S.L.
Spain

Periodic Reporting for period 1 - RIS (Robot Immune System)

Reporting period: 2019-07-01 to 2019-11-30

Summary of the context and overall objectives of the project

Robots are increasingly taking part in our daily lives, especially in the last 5-10 years. According to the International Federation of Robotics (IFR) the demand for industrial robots has considerably accelerated since 2010, with more than 400,000 units sold in 2018 reaching a total of more than 2 million industrial robots operating worldwide. However, this important growth, which is contributing to the rapid transition to Industry 4.0 has brought other problems related to security: most of modern robots have connectivity requirements that make them more vulnerable and open to cyber-attacks.

Reports show an increase in 27% of the number of “unique incidents” (entire malicious campaigns) regarding cybersecurity, of which 58% was directed to companies. Companies of all types are aware of this fact, as surveys conducted by EY show that 53% of companies have increased their cybersecurity budget in 2019 and 65% of them foresee to increase it further next year.

In order to address this growing need, Alias Robotics has developed the Robot Immune System (RIS). RIS is a unique product that provides robots with a complete defensive system, a real-time threat prevention system to protect robots against known and unknown vulnerabilities. Based on Artificial Intelligence techniques (AI) and inspired by the human immune system, RIS brings together state of the art of hardware and software design and constitutes a Universal product adapted to the requirements of modern robots.

Work performed from the beginning of the project to the end of the period covered by the report and main results achieved so far

During SME Instrument Phase I, Alias has prepared a feasibility study, comprising 3 tasks: market, business model and revenue scheme.
The main objective is the analysis of the innovative value proposition that enables the sale of the product with enough profit margins to allow the return on investment and ensure the future sustainability.

The main business takeaway of this study is that RIS will have a greater need and/or acceptance than initially expected, which in turn results in a growing market demand. Apart from that, the need to initially prioritise the industrial market has been detected, with a later diversification towards the commercial and consumer niches.

Progress beyond the state of the art and expected potential impact (including the socio-economic impact and the wider societal implications of the project so far)

The feasibility study has allowed Alias to conduct meetings with potential customers and verify that RIS is more than enough from a technical standpoint. Operational aspects of the project have also been verified.

RIS provides several clear benefits compared to available cibersecurity solutions:

- Inmune inspired cognition for deep traffic inspection
- Plug and play
- Robot and interface agnostic
- No latencies, warranting full availability

Thanks to RIS, Alias expects to create 210 direct + indirect jobs by 2026, capturing 3.5% of the Spanish market share and 1.2% of the European share. This results in 8 M€ turnover in 2026.

captura-de-pantalla-2019-11-28-a-las-12-28-41.png

captura-de-pantalla-2019-11-28-a-las-12-28-55.png

captura-de-pantalla-2019-11-28-a-las-12-29-22.png